Synthetic Molecules Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
- Satisfied Charges ₹ 3.97 M
- Revenue Growth 49.88%
- Profit Growth 7.78%
- Ebitda 96.70%
- Net Worth 33.70%
- Total Assets 81.25%
About Synthetic Molecules
Synthetic Molecules Private Limited (SMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 September 2003 and has a history of 21 years and four months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 M. The company has closed loans amounting to ₹3.97 M, as per Ministry of Corporate Affairs (MCA) records.
Kishor Thakur and Akshay Thakur serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24117MP2003PTC016054
- Company No.
016054
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
What products or services does Synthetic Molecules Private Limited offer?
Synthetic Molecules Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cardiac Drugs, Pharma Ingredients & Raw Materials, API Intermediate, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Diabetes Medicine, Common Disease Medicines, Eye Drops, Industrial Chemicals & Supplies.
Who are the key members and board of directors at Synthetic Molecules?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishor Thakur  | Director | 01-Sep-2003 | Current |
| Akshay Thakur | Director | 01-Sep-2003 | Current |
Financial Performance of Synthetic Molecules.
Synthetic Molecules Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.88% increase. The company also saw a slight improvement in profitability, with a 7.78% increase in profit. The company's net worth Soared by an impressive increase of 33.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synthetic Molecules?
Unlock access to Synthetic Molecules's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Extol Impex India Private LimitedAkshay Thakur is a mutual person
Shreepati Molecules Private LimitedKishor Thakur is a mutual person
- Siddheshwar Lifescience Private Limited
Akshay Thakur is a mutual person
Charges (Loans)
₹3.50 M
₹3.97 M
Charges Breakdown by Lending Institutions
- Others : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Apr 2024 | Others | ₹2.00 M | Open |
| 16 Apr 2022 | Others | ₹1.50 M | Open |
| 10 Mar 2021 | Others | ₹0.30 M | Satisfied |
| 27 Aug 2019 | Others | ₹1.45 M | Satisfied |
| 02 Nov 2018 | Others | ₹0.10 M | Satisfied |
How Many Employees Work at Synthetic Molecules?
Unlock and access historical data on people associated with Synthetic Molecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synthetic Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthetic Molecules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
